Načítá se...
Growth hormone therapy in patients with Noonan syndrome
Noonan syndrome (NS) is an autosomal dominant disorder that involves multiple organ systems, with short stature as the most common presentation (>70%). Possible mechanisms of short stature in NS include growth hormone (GH) deficiency, neurosecretory dysfunction, and GH resistance. Accordingly, GH...
Uloženo v:
| Vydáno v: | Ann Pediatr Endocrinol Metab |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Korean Society of Pediatric Endocrinology
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6312920/ https://ncbi.nlm.nih.gov/pubmed/30599478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6065/apem.2018.23.4.176 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|